Aytu BioPharma, Inc. Common Stock (NASDAQ: AYTU) last traded at $2.04, up 2.51% on the session. The quote above updates while this page is open; the figures below are drawn from Aytu BioPharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Aytu BioPharma, Inc. Common Stock trades on NASDAQ under the ticker AYTU. Its market capitalisation is $22.17 million.
Valuation measures for Aytu BioPharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $22.17M |
|---|---|
| Enterprise value | $65.59M |
| Price / sales | 0.39 |
| Price / book | 0.63 |
| Beta | 0.72 |
Trailing-twelve-month figures tagged in Aytu BioPharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $57.57M |
|---|---|
| Net income (TTM) | -$14.25M |
| EPS (TTM) | -$1.16 |
| Gross margin | 63.95% |
| Operating margin | -14.44% |
| Return on equity | -40.40% |
| Cash | $26.31M |
Range and volume for AYTU over the past 52 weeks.
| 52-week high | $3.07 |
|---|---|
| 52-week low | $1.80 |
| Volume | 218 |
| Average volume | 33.5K |
| Previous close | $1.99 |
Invest a chosen dollar amount in Aytu BioPharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AYTU.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.